Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levosimendan Efficacy Assessment by CPET
NCT02261948Phase 4Completed
- Sponsor
- Centro Cardiologico Monzino
- Start
- Sep 2012
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in heart failure (HF) comparing Levosimendan with Placebo (2 arms). Primary endpoint: Change in Peak Oxygen Consumption at 48 hours. Started Sep 2012; status: completed.
02
Drugs
levosimendan
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT02261948.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02261948.